Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ON vs GSK✓SelectedUSD · GSKON vs GSK performance historyLatest closeAs of-4.74%11/16
Stock and ETF performance explorer

ON vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+8.9%
GSK return
+46.9%
Excess return
-38.0%
Maximum drawdown
-70.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.7%-0.1%-4.7%-4.7%
7D-2.1%-1.3%-0.7%-1.8%
30D-6.0%+2.7%-8.7%-6.4%
3M-18.1%+2.7%-20.8%-18.6%
6M-40.2%+3.3%-43.5%-41.1%
YTD+25.0%+6.5%+18.5%+21.7%
1Y+44.3%+10.7%+33.6%+39.1%
3Y-2.5%+64.4%-66.9%-17.6%
5Y+8.9%+46.7%-37.7%-9.8%
All+8.9%+46.9%-38.0%-9.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling